DENTSPLY SIRONA INC

Insider CFO buys 24k RSUs at $11.41—signaling confidence in DENTSPLY SIRONA’s long‑term strategy amid a 17% share slide.

Executive shares sold at DENTSPLY SIRONA show routine liquidity, not a sell‑off, as insiders keep long‑term stakes while the firm pushes its digital‑dentistry and implant innovations.

Insider buying continues at DENTSPLY SIRONA: non‑executive Jonathan Jay Mazelsky’s recent purchase of 10,000 shares signals confidence amid a flat market and offers investors a nuanced view of the dental‑care company’s prospects.

Insider buying surge at DENTSPLY SIRONA signals strong confidence in its dental tech pipeline—high‑dose‑reduced imaging, 12% better implant survival, and 20% faster procedures—boosting future growth potential.

Insider buying at DENTSPLY SIRONA signals confidence amid a 32 % share decline, highlighting growth potential in implants and imaging despite negative earnings.

Insider buying at DENTSPLY SIRONA signals potential upside: director Lucier Gregory T.’s largest share purchase shows confidence amid a low price, negative P/E, and strong dental‑equipment fundamentals. Explore why this could spur a rebound.

Insider buying spurs optimism for DENTSPLY SIRONA amid dental‑equipment sector shifts, highlighting management confidence, digital‑health growth, and market‑share gains.

Andrea Frohning’s 5,957‑share sale at DENTSPLY SIRONA is routine tax‑covering activity, leaving long‑term investors a solid dental‑tech play amid steady gains and no major volatility.

Insider buys of DENTSPLY SIRONA signal bullish momentum—highlighting a strategic edge, rising social buzz, and potential mid‑term upside amid earnings optimism.

Discover how Dentsply Sirona’s insider buying signals bullish growth and investor confidence amid market volatility.